Biopharma Business

Tag "clinical trial"

Promising Preclinical Results of Zika Virus Vaccine

    Promising Preclinical Results of Zika Virus Vaccine

  Preclinical results of research by City College of New York scientists and TechnoVax, Inc. in animal models demonstrate favorable outcomes in developing a vaccine against the mosquito-borne Zika virus.

Read Full Article

Landmark clinical trial to help juvenile idiopathic arthritis sufferers

A clinical trial funded by Arthritis Research UK and the National Institute for Health Research (NIHR) led by professors from the Universities of Liverpool and Bristol has discovered a drug

Read Full Article

French Biotech Could Be Taking its Diabetes Drug to Phase III on its own

Poxel was able to score positive results for its type 2 diabetes drug in a Phase IIb study in Japan, preparing the company to go for a Phase III program. Poxel, one of

Read Full Article

First patient recruited in Phase Ib trial of TG02

The first patient has been recruited in an exploratory Phase Ib clinical trial of Targovax’s second product from its RAS-peptide immunotherapy platform, TG02. In the open-label, non-randomised trial — to

Read Full Article

Norway Brings Another Cancer Vaccine to the Clinic

Targovax has recruited its first patient in a Phase Ib trial for its new cancer vaccine TG02 targeting mutations of the RAS gene. Mutations of the RAS gene disrupt normal cell

Read Full Article

Allergan and Novartis Collaborate on Multi-Therapy Treatment for NASH

Allergan, a global biopharmaceutical company, announced that it has entered into a clinical trial agreement with Novartis to conduct a Phase 2b study, using Allergan’s cenicriviroc (CVC) and Novartis’ lead FXR

Read Full Article

Operating expenses rise at Mainstay Medical as new trial begins

Medical device firm Mainstay Medical said operating expenses rose by $3.9 million for 2016 to $16.8 million as Mainstay kicked off its ReActiv-8 B clinical trial and began commercialising the

Read Full Article

Orphan Drug Natpar Receives EMA Recommendation

The European Medicines Agency (EMA) announced on Feb. 24, 2017 that its Committee for Medicinal Products for Human Use (CHMP) has granted conditional marketing authorization in the European Union to Natpar

Read Full Article

Dutch and German Biotechs enter the Clinic with their First Lanthipeptide

Lanthio Pharma has initiated a Phase I clinical trial with its lanthipeptide candidate MOR107, which is being developed as a therapy for diabetic nephropathy. Lanthio Pharma, a Dutch subsidiary of

Read Full Article

Faron Pharmaceuticals recruits first patient for new Traumakine trial

Faron Pharmaceuticals has recruited its first patient to a phase II clinical trial of its lead drug, Traumakine, in the treatment of organ failure after a ruptured abdominal aorta aneurysm

Read Full Article

Liverpool Uni leads clinical trial of promising osteoarthritis drug

The University of Liverpool, in partnership with AKL Research and Development, will lead a clinical trial testing the potential of a new therapy for osteoarthritis (OA), the most common type

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements